Paras Healthcare Ltd (NSE: PARASHLTH, BSE: 545005) is a Gurugram, Haryana-based company in the Hospitals and Healthcare Centers industry. With a market capitalisation of ₹7,999 Cr, it ranks #651 by market cap among the 6,197 Indian listed companies on FinBizNet, and #15 of 46 in Hospitals and Healthcare Centers. At ₹752.00 (as of 9 Nov 2026), the share price is 5.3% below its 52-week high of ₹794.40 and 6.5% above its 52-week low of ₹706.00.
| Current Price | ₹752.00 |
|---|---|
| Market Cap | ₹7,999 Cr |
| NSE Symbol | PARASHLTH |
| BSE Code | 545005 |
| Sector | Health Care > Health Care Equipment and Services > Health Care Providers and Services |
| Sub-Industry | Health Care Facilities > Hospitals and Healthcare Centers |
| P/E Ratio | 170.3 |
| Return on Assets | 18.20% |
| 52-Week Range | ₹706.00 – ₹794.40 |
| Headquarters | Gurugram, Haryana |
| Website | www.parashospitals.com |
| Revenue | ₹511 Cr |
|---|---|
| Net Profit | ₹40 Cr |
| Net Margin | 7.9% |
| EPS (Basic) | ₹4.00 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Promoters held 63.95% of Paras Healthcare Ltd's shares as of Oct 2026. Delivery averaged 50.1% of traded volume across 5 NSE sessions (3 Nov 2026 – 9 Nov 2026).
Paras Healthcare Limited provides tertiary and quaternary healthcare services. The company provides cardiac sciences, neurosciences, oncology sciences, gastro sciences, orthopedics and sports injury, and renal sciences services. It offers services, such as cardio thoracic vascular surgery and cardiology; medical, radiation, surgical, and hemato oncology, as well as nuclear medicine and bone marrow transplant; and neuroscience, neuro intervention, neurology, and spine surgery. The company also provides gastrointestinal surgery, gastroenterology, and liver transplant; nephrology, urology, and kidney transplant; general and minimal access surgery, obstetrics, gynecology, paediatrics, internal medicine, pulmonology, plastic and reconstructive surgery, and endocrinology as well as ear, nose, throat, neck and head surgery. Paras Healthcare Limited was incorporated in 1987 and is based in Gurugram, India.
1. Providing Healthcare Services-This segment provides healthcare services. 2. NA-NA 3. NA-NA 4. NA-NA
1. Providing Healthcare Services-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Apollo Hospitals Enterprise Limited | ₹1,21,627 Cr | 62.7 | 21.50% | ₹7,615 Cr | +9.3% |
| Manipal Health Enterprises Ltd | ₹85,960 Cr | 85.2 | — | ₹3,091 Cr | — |
| Max Healthcare Institute Ltd | ₹85,953 Cr | 59.8 | 14.33% | ₹2,569 Cr | -20.2% |
| Aster Dm Healthcare Limited (Asterdm) | ₹58,658 Cr | 89.6 | 10.07% | ₹2,829 Cr | +8.1% |
| Fortis Healthcare Ltd. | ₹57,490 Cr | 55.2 | 11.01% | ₹2,735 Cr | -24.9% |
| Narayana Hrudayalaya Limited | ₹37,253 Cr | 46 | 19.85% | ₹2,844 Cr | +5.9% |
| Global Health Ltd (Medanta) | ₹34,910 Cr | 62.8 | 15.03% | ₹1,469 Cr | +12.1% |
| Krishna Institute Of Medical Science (KIMS) | ₹28,846 Cr | 119.6 | 9.72% | ₹1,344 Cr | -0.5% |
| Paras Healthcare Ltd | ₹7,999 Cr | 170.3 | — | ₹511 Cr | — |
Listed by market capitalisation. Ratios are shown for context only.
Paras Healthcare Ltd is trading at ₹752.00, with a market capitalisation of ₹7,999 Cr.
Paras Healthcare Ltd operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Facilities > Hospitals and Healthcare Centers).
Paras Healthcare Ltd has a P/E of 170.3.
Paras Healthcare Ltd is listed on the NSE under the symbol PARASHLTH and on the BSE under the scrip code 545005.
In Q2 FY27, Paras Healthcare Ltd reported revenue of ₹511 Cr and net profit of ₹40 Cr, with basic EPS of ₹4 (consolidated, parsed from the company's exchange filing).
Promoters held 63.95% of Paras Healthcare Ltd's shares as of Oct 2026.
Data as of 9 Nov 2026. Descriptive market data only — not investment advice.